There were 1,463 press releases posted in the last 24 hours and 438,526 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
TCR² Therapeutics to Announce Interim Data from Phase 1/2 Clinical Trial of TC-210 in Mesothelin-Expressing Solid Tumors

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image